Crossmark

Inhaled nitric oxide as an independent intervention to lower the risk of bronchopulmonary dysplasia in preterm infants (< 33 weeks) with pulmonary hypertension within the initial 3 days of life

Crossref DOI link: https://doi.org/10.1038/s41598-025-06055-0

Published Online: 2025-07-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Azad, Tasnim

Li, Li

Wang, Shuo

Yue, ShaoJie

Yu, XiaoHe

Liao, ZhengChang

Cao, ChuanDing

Ding, Ying

Lv, Mei

Liu, Teng

Chu, MeiYan

Wang, MingJie
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81873852, 81873852, 81873852, 81873852, 81873852, 81873852, 81873852, 81873852, 81873852, 81873852, 81873852, 81873852)
License Information

Text and Data Mining valid from 2025-07-02

Version of Record valid from 2025-07-02
More Information

Article History

Received: 11 March 2025

Accepted: 5 June 2025

First Online: 2 July 2025

Declarations

:

: This study was reviewed and approved by the Institutional Review Board (IRB) of Xiangya Hospital, Central South University (Approval Number: 202406249). The research complies with the ethical standards of the institution and international ethical guidelines for human subject research. Given the retrospective nature of the study, the requirement for informed consent was waived by the IRB.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below